Literature DB >> 29514744

Association between blood eosinophil count with asthma hospital readmissions.

Francisco-Javier Gonzalez-Barcala1, Maria-Esther San-Jose2, Juan-José Nieto-Fontarigo3, Jose-Martín Carreira4, Uxio Calvo-Alvarez5, Maria-Jesus Cruz6, David Facal7, Maria-Teresa Garcia-Sanz8, Luis Valdes-Cuadrado9, Francisco-Javier Salgado3.   

Abstract

INTRODUCTION: The presence of eosinophils in asthma inflammation is a relevant factor in the pathophysiology of the disease, however the relationship between the blood eosinophil count (BEC) with asthma severity and prognosis is still under debate. The aim of this work is to analyze the relationship between the BEC levels and hospital readmissions in patients with asthma.
MATERIAL AND METHODS: A review was retrospectively carried out on all admissions of patients over 18 years old due to exacerbation of asthma occurring in our hospital between the years 2000 and 2010. The personal characteristics and the asthma personal history of each patient were recorded. The BEC was determined from the first blood sample taken from the patient after their arrival at the hospital. Hospital early, late and frequent readmissions were analyzed using 4 cut-off points; less than 150 eosinophils/μL vs ≥150/μL, less than 200 vs 200 /μL, less than 300 vs ≥300/μL, and less than 400 vs ≥400/μL.
RESULTS: We have included 1316 patients, 70% of whom are women, as well as a mean age of 60 years, and a mean FEV1 of 73.5% of the reference value. The mean eosinophil blood count was 201.7 cells/μL. A BEC ≥300 cells/μL showed a reduction of risk of late readmission of 42%, a BEC ≥400 cells/μL showed a reduction in late readmission risk of 41% and decrease in frequent late readmission of 63%.
CONCLUSIONS: Our study appears to support that an elevated BEC is associated with a lower incidence of asthma hospital readmissions.
Copyright © 2018 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Asthma; Eosinophils; Hospital admissions; Prognosis; Readmissions; Severity

Mesh:

Year:  2018        PMID: 29514744     DOI: 10.1016/j.ejim.2018.02.034

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  4 in total

1.  Differences in Inflammatory Cytokine Profile in Obesity-Associated Asthma: Effects of Weight Loss.

Authors:  Marina Bantulà; Valeria Tubita; Jordi Roca-Ferrer; Joaquim Mullol; Antonio Valero; Irina Bobolea; Mariona Pascal; Ana de Hollanda; Josep Vidal; César Picado; Ebymar Arismendi
Journal:  J Clin Med       Date:  2022-06-29       Impact factor: 4.964

2.  The biomarkers suPAR and blood eosinophils are associated with hospital readmissions and mortality in asthma - a retrospective cohort study.

Authors:  K E J Håkansson; Line J H Rasmussen; Nina S Godtfredsen; Oliver D Tupper; Jesper Eugen-Olsen; Thomas Kallemose; Ove Andersen; Charlotte Suppli Ulrik
Journal:  Respir Res       Date:  2019-11-15

3.  Prevalence of eosinophilic, atopic, and overlap phenotypes among patients with severe asthma in Saudi Arabia: a cross-sectional study.

Authors:  Hamdan Al-Jahdali; Siraj Wali; Amr S Albanna; Riyad Allehebi; Hussein Al-Matar; Mohamed Fattouh; Maarten Beekman
Journal:  BMC Pulm Med       Date:  2022-02-17       Impact factor: 3.317

4.  Association between blood eosinophil count and risk of readmission for patients with asthma: Historical cohort study.

Authors:  Marjan Kerkhof; Trung N Tran; Maarten van den Berge; Guy G Brusselle; Gokul Gopalan; Rupert C M Jones; Janwillem W H Kocks; Andrew Menzies-Gow; Javier Nuevo; Ian D Pavord; Sarang Rastogi; David B Price
Journal:  PLoS One       Date:  2018-07-25       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.